You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 269 No. 23, June 16, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (285)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevalence of High Blood Cholesterol Among US Adults

An Update Based on Guidelines From the Second Report of the National Cholesterol Education Program Adult Treatment Panel

Christopher T. Sempos, PhD; James I. Cleeman, MD; Margaret D. Carroll, MSPH; Clifford L. Johnson, MSPH; Paul S. Bachorik, PhD; David J. Gordon, MD, PhD; Vicki L. Burt, ScM, RN; Ronette R. Briefel, DrPH, RD; Clarice D. Brown, MS; Kenneth Lippel, PhD; Basil M. Rifkind, MD

JAMA. 1993;269(23):3009-3014.


Abstract

Objective.
—To estimate the current levels and trends in the proportion of US adults with high blood cholesterol based on guidelines from the second report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP II).

Design.
—Nationally representative cross-sectional surveys.

Setting/Participants.
—Data for 7775 participants 20 years of age and older from phase 1 of the third National Health and Nutrition Examination Survey (NHANES III) (data collected from 1988 through 1991) and for 9797 participants 20 through 74 years of age from NHANES II (data collected from 1976 through 1980) were used.

Results.
—From the data collection period in NHANES II (1976 through 1980) to the period in NHANES III (1988 through 1991), the proportion of adults with high blood cholesterol levels (≥240 mg/dL [6.21 mmol/L]) fell from 26% to 20%, while the proportion with desirable levels (<200 mg/dL [5.17 mmol/L]) rose from 44% to 49%. Currently, using the ATP II guidelines and NHANES III data, 40% of all adults 20 years of age and older would require fasting lipoprotein analysis; and 29% of all adults would be candidates for dietary therapy (as compared with 36%, using NHANES II data). Based on 1990 population data, it is estimated that approximately 52 million Americans 20 years of age and older would be candidates for dietary therapy. Assuming that dietary intervention would reduce low-density lipoprotein (LDL) cholesterol levels by 10%, as many as 7% of all adult Americans (approximately 12.7 million) might be candidates for cholesterol-lowering drugs. This estimate reflects approximately 4 million adults with established coronary heart disease, of whom half are aged 65 years and older, and up to 8.7 million adults without established coronary heart disease, of whom up to 3.1 million are aged 65 years and older.

Conclusions.
—Substantial progress has been made in reducing the prevalence of high blood cholesterol; yet a large proportion of all adults, approximately 29%, require dietary intervention for high blood cholesterol.

(JAMA. 1993;269:3009-3014)



Author Affiliations

From the Division of Health Examination Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Md (Drs Sempos and Briefel, Mss Carroll and Burt, and Mr Johnson); the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Drs Cleeman, Gordon, Lippel, and Rifkind, and Ms Brown); and The Johns Hopkins Hospital, The Children's Medical and Surgical Center, Baltimore, Md (Dr Bachorik).


Footnotes

Reprint requests to the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg 31, Room 4A-05, Bethesda, MD 20892 (Dr Cleeman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hypertension in rheumatoid arthritis
Panoulas et al.
Rheumatology (Oxford) 2008;47:1286-1298.
ABSTRACT | FULL TEXT  

Cardiovascular Risk Education and Social Support (CaRESS): Report of a Randomized Controlled Trial from the Kentucky Ambulatory Network (KAN)
Pearce et al.
J Am Board Fam Med 2008;21:269-281.
ABSTRACT | FULL TEXT  

A Combination Therapy Including Psyllium and Plant Sterols Lowers LDL Cholesterol by Modifying Lipoprotein Metabolism in Hypercholesterolemic Individuals
Shrestha et al.
J. Nutr. 2006;136:2492-2497.
ABSTRACT | FULL TEXT  

Recent Trends in Cardiovascular Complications Among Men and Women With and Without Diabetes
Booth et al.
Diabetes Care 2006;29:32-37.
ABSTRACT | FULL TEXT  

Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey, 1980-1982 to 2000-2002
Arnett et al.
Circulation 2005;112:3884-3891.
ABSTRACT | FULL TEXT  

Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy: The Women's Health Initiative Observational Study
Howard et al.
Circulation 2005;111:1462-1470.
ABSTRACT | FULL TEXT  

Increased ApoB in Small Dense LDL Particles Predicts Premature Coronary Artery Disease
Brunzell
Arterioscler. Thromb. Vasc. Bio. 2005;25:474-475.
FULL TEXT  

Eliminating Diagnostic Drift in the Validation of Acute In-Hospital Myocardial Infarction--Implication for Documenting Trends across 25 Years: The Minnesota Heart Survey
Crow et al.
Am J Epidemiol 2005;161:377-388.
ABSTRACT | FULL TEXT  

Seasonal Variation in Serum Cholesterol Levels: Treatment Implications and Possible Mechanisms
Ockene et al.
Arch Intern Med 2004;164:863-870.
ABSTRACT | FULL TEXT  

Diagnostic and Treatment Decisions in US Healthcare
Kaplan et al.
J Health Psychol 2004;9:29-40.
ABSTRACT  

Undiagnosed Hypertension and Hypercholesterolemia Among Uninsured and Insured Adults in the Third National Health and Nutrition Examination Survey
Ayanian et al.
AJPH 2003;93:2051-2054.
FULL TEXT  

CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans
Chandler et al.
J. Lipid Res. 2003;44:1887-1901.
ABSTRACT | FULL TEXT  

High Methionine and Cholesterol Diet Abolishes Endothelial Relaxation
Zulli et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:1358-1363.
ABSTRACT | FULL TEXT  

Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial
Sabate et al.
Am. J. Clin. Nutr. 2003;77:1379-1384.
ABSTRACT | FULL TEXT  

Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia Among US Adults: Findings From the National Health and Nutrition Examination Survey, 1999 to 2000
Ford et al.
Circulation 2003;107:2185-2189.
ABSTRACT | FULL TEXT  

Food Products Containing Free Tall Oil-Based Phytosterols and Oat {beta}-Glucan Lower Serum Total and LDL Cholesterol in Hypercholesterolemic Adults
Maki et al.
J. Nutr. 2003;133:808-813.
ABSTRACT | FULL TEXT  

Awareness, treatment, and control of vascular risk factors in African Americans with stroke
Ruland et al.
Neurology 2003;60:64-68.
ABSTRACT | FULL TEXT  

Behavioral Medicine in the Prevention and Treatment of Cardiovascular Disease
Graves and Miller
Behav Modif 2003;27:3-25.
ABSTRACT  

Fifteen-Year Trends in Cardiovascular Risk Factors (1980-1982 through 1995-1997): The Minnesota Heart Survey
Arnett et al.
Am J Epidemiol 2002;156:929-935.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Its Relationship to Lipid and Glucose Metabolism in Diabetic and Nondiabetic Postmenopausal Women: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
Crespo et al.
Diabetes Care 2002;25:1675-1680.
ABSTRACT | FULL TEXT  

Primary Prevention Drug Therapy: Can It Meet Patients' Requirements for Reduced Risk?
Llewellyn-Thomas et al.
Med Decis Making 2002;22:326-339.
ABSTRACT  

Use of Cholesterol-Lowering Therapy by Elderly Adults After Myocardial Infarction
Ayanian et al.
Arch Intern Med 2002;162:1013-1019.
ABSTRACT | FULL TEXT  

Disparities in the Diagnosis and Pharmacologic Treatment of High Serum Cholesterol by Race and Ethnicity: Data From the Third National Health and Nutrition Examination Survey
Nelson et al.
Arch Intern Med 2002;162:929-935.
ABSTRACT | FULL TEXT  

Supplemental Insurance and Use of Effective Cardiovascular Drugs Among Elderly Medicare Beneficiaries With Coronary Heart Disease
Federman et al.
JAMA 2001;286:1732-1739.
ABSTRACT | FULL TEXT  

Major risk factors and coronary heart disease: much has been achieved but crucial challenges remain
Daviglus and Stamler
J Am Coll Cardiol 2001;38:1018-1022.
FULL TEXT  

Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population: Report From the Third National Health and Nutrition Examination Survey
Qureshi et al.
Arch Intern Med 2001;161:1621-1628.
ABSTRACT | FULL TEXT  

Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997 : The Minnesota Heart Survey
McGovern et al.
Circulation 2001;104:19-24.
ABSTRACT | FULL TEXT  

Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet
Maki et al.
Am. J. Clin. Nutr. 2001;74:33-43.
ABSTRACT | FULL TEXT  

Are cardiovascular disease trends driven by gadflies?
Sans and Evans
Int J Epidemiol 2001;30:624-625.
FULL TEXT  

Applicability of Cholesterol-Lowering Primary Prevention Trials to a General Population: The Framingham Heart Study
Lloyd-Jones et al.
Arch Intern Med 2001;161:949-954.
ABSTRACT | FULL TEXT  

Effects of Policosanol in Older Patients With Type II Hypercholesterolemia and High Coronary Risk
Castaño et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001;56:186M-193.
ABSTRACT | FULL TEXT  

"The Lower the Better" in Hypercholesterolemia Therapy: A Reliable Clinical Guideline?
Jacobson
ANN INTERN MED 2000;133:549-554.
ABSTRACT | FULL TEXT  

Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia
Anderson et al.
Am. J. Clin. Nutr. 2000;71:1433-1438.
ABSTRACT | FULL TEXT  

Differential Effect of National Cholesterol Education Program (NCEP) Step II Diet on HDL Cholesterol, Its Subfractions, and Apoprotein A-I Levels in Hypercholesterolemic Women and Men After 1 Year : The beFIT Study
Walden et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:1580-1587.
ABSTRACT | FULL TEXT  

Impact of Evidence-Based "Clinical Judgment" on the Number of American Adults Requiring Lipid-Lowering Therapy Based on Updated NHANES III Data
Jacobson et al.
Arch Intern Med 2000;160:1361-1369.
ABSTRACT | FULL TEXT  

Estimating the Long-Term Effects of Storage at -70 {degrees}C on Cholesterol, Triglyceride, and HDL-Cholesterol Measurements in Stored Sera
Shih et al.
Clin. Chem. 2000;46:351-364.
ABSTRACT | FULL TEXT  

Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women
Fak et al.
Eur Heart J 2000;21:190-197.
ABSTRACT  

Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials1
Anderson et al.
Am. J. Clin. Nutr. 2000;71:472-479.
ABSTRACT | FULL TEXT  

Colesevelam Hydrochloride (Cholestagel): A New, Potent Bile Acid Sequestrant Associated With a Low Incidence of Gastrointestinal Side Effects
Davidson et al.
Arch Intern Med 1999;159:1893-1900.
ABSTRACT | FULL TEXT  

The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines
Goldman et al.
J Am Coll Cardiol 1999;34:768-776.
ABSTRACT | FULL TEXT  

New Perspectives on the Management of Low Levels of High-Density Lipoprotein Cholesterol
Harper and Jacobson
Arch Intern Med 1999;159:1049-1057.
ABSTRACT | FULL TEXT  

Forecasting Patient Outcomes in the Management of Hyperlipidemia
Brier et al.
Arch Intern Med 1999;159:569-575.
ABSTRACT | FULL TEXT  

The National Cholesterol Education Program: Progress and Prospects
Cleeman and Lenfant
JAMA 1998;280:2099-2104.
ABSTRACT | FULL TEXT  

Maximizing the Cost-effectiveness of Lipid-Lowering Therapy
Jacobson et al.
Arch Intern Med 1998;158:1977-1989.
ABSTRACT | FULL TEXT  

Impact of Major Cardiovascular Disease Risk Factors, Particularly in Combination, on 22-Year Mortality in Women and Men
Lowe et al.
Arch Intern Med 1998;158:2007-2014.
ABSTRACT | FULL TEXT  

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs et al.
JAMA 1998;279:1615-1622.
ABSTRACT | FULL TEXT  

Setting the TONE for Ending the Hypertension Epidemic
Stamler
JAMA 1998;279:878-879.
FULL TEXT  

Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects : The Delta Study, Protocol 1
Ginsberg et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:441-449.
ABSTRACT | FULL TEXT  

Cholesterol Management in Theory and Practice
Gotto
Circulation 1997;96:4424-4430.
ABSTRACT | FULL TEXT  

Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III)
Bachorik et al.
Clin. Chem. 1997;43:2364-2378.
ABSTRACT | FULL TEXT  

Cardiovascular Disease in Women : A Statement for Healthcare Professionals From the American Heart Association
Mosca et al.
Circulation 1997;96:2468-2482.
FULL TEXT  

A Comparison of Estrogen Replacement, Pravastatin, and Combined Treatment for the Management of Hypercholesterolemia in Postmenopausal Women
Davidson et al.
Arch Intern Med 1997;157:1186-1192.
ABSTRACT  

National Cholesterol Education Program Recommendations for Cholesterol Testing in Young Adults : A Science-Based Approach
Cleeman and Grundy
Circulation 1997;95:1646-1650.
FULL TEXT  

Lipoprotein Lipid Response to the National Cholesterol Education Program Step II Diet by Hypercholesterolemic and Combined Hyperlipidemic Women and Men
Walden et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:375-382.
ABSTRACT | FULL TEXT  

Distribution and Correlates of Lipids and Lipoproteins in Elderly Japanese-American Men: The Honolulu Heart Program
Burchfiel et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:1356-1364.
ABSTRACT | FULL TEXT  

Prevalence of Hypercholesterolemia Among Siblings of Persons With Premature Coronary Heart Disease: Application of the Second Adult Treatment Panel Guidelines
Allen et al.
Arch Intern Med 1996;156:1654-1660.
ABSTRACT  

Beyond Low-Density Lipoprotein Cholesterol: A Perspective on Low High-Density Lipoprotein Disorders and Lp(a) Lipoprotein Excess
Rosenson
Arch Intern Med 1996;156:1278-1284.
ABSTRACT  

Recent Trends in Acute Coronary Heart Disease -- Mortality, Morbidity, Medical Care, and Risk Factors
McGovern et al.
NEJM 1996;334:884-890.
ABSTRACT | FULL TEXT  

Leisure-Time Physical Activity Among US Adults: Results From the Third National Health and Nutrition Examination Survey
Crespo et al.
Arch Intern Med 1996;156:93-98.
ABSTRACT  

Survival after the Age of 80 in the United States, Sweden, France, England, and Japan
Manton and Vaupel
NEJM 1995;333:1232-1235.
ABSTRACT | FULL TEXT  

Environmental and Policy Approaches to Cardiovascular Disease Prevention Through Nutrition: Opportunities for State and Local Action
Glanz et al.
Health Educ Behav 1995;22:512-527.
ABSTRACT  

Combined Effects of HDL Cholesterol, Triglyceride, and Total Cholesterol Concentrations on 18-Year Risk of Atherosclerotic Disease
Burchfiel et al.
Circulation 1995;92:1430-1436.
ABSTRACT | FULL TEXT  

HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons
Corti et al.
JAMA 1995;274:539-544.
ABSTRACT  

Efficacy of Individualized Dietary Advice for Lowering Cholesterol-Reply
Denke
Arch Intern Med 1995;155:1684-1685.
ABSTRACT  

Efficacy of a National Cholesterol Education Program Step 2 Diet in Normolipidemic and Hypercholesterolemic Middle-Aged and Elderly Men and Women
Schaefer et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1079-1085.
ABSTRACT | FULL TEXT  

Population Awareness and Control of Hypertension and Hypercholesterolemia: The Atherosclerosis Risk in Communities Study
Nieto et al.
Arch Intern Med 1995;155:677-684.
ABSTRACT  

Efficacy of Low-Dose Cholesterol-Lowering Drug Therapy in Men With Moderate Hypercholesterolemia
Denke and Grundy
Arch Intern Med 1995;155:393-399.
ABSTRACT  

Enthusiasm Misplaced?: Revisiting Cholesterol Screening
Oderkirk
J Holist Nurs 1994;12:414-424.
ABSTRACT  

Dietitian Practices for Adult Outpatients With Hypercholesterolemia Referred by Physicians: The Minnesota Dietitian Survey
Elson et al.
Arch Fam Med 1994;3:1073-1080.
ABSTRACT  

Lack of Association Between Cholesterol and Coronary Heart Disease Mortality and Morbidity and All-Cause Mortality in Persons Older Than 70 Years
Krumholz et al.
JAMA 1994;272:1335-1340.
ABSTRACT  

Cholesterol in the Elderly: Is It Important?
Hulley and Newman
JAMA 1994;272:1372-1374.
ABSTRACT  

Individual Responsiveness to a Cholesterol-Lowering Diet in Postmenopausal Women With Moderate Hypercholesterolemia
Denke
Arch Intern Med 1994;154:1977-1982.
ABSTRACT  

Prevalence of Adults With No Known Major Risk Factors for Coronary Heart Disease--Behavioral Risk Factor Surveillance System, 1992
JAMA 1994;271:741-742.
 

Hypercholesterolemia in Postmenopausal Women: Metabolic Defects and Response to Low-Dose Lovastatin
Arca et al.
JAMA 1994;271:453-459.
ABSTRACT  

State-Specific Changes in Cholesterol Screening--Behavioral Risk Factor Surveillance System, 1988-1991
JAMA 1993;270:1413-1414.
 

CHOLESTEROL LEVELS HAVE FALLEN IN U.S. ADULTS
JWatch General 1993;1993:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.